Tests for Chemotherapeutic Drug resistance
Researchers from Japan are designing some tests to be able to identify patients who will be likely to be resistant to a drug named IMATINIB that is used for treating leukemia, a type of cancer that attacks our Red Blood cells.
The resistance of the drug Imatinib usually occurs in cases of relapse patients.
The tests are to determine and somehow help medical professionals on knowing whether or not the patient is resistant to the drug.
Researchers from Japan are designing some tests to be able to identify patients who will be likely to be resistant to a drug named IMATINIB that is used for treating leukemia, a type of cancer that attacks our Red Blood cells.
The drug, also known by the brand name Gleevec is manufactured by the company Novartis used to treat Chronic Myeloid Leukemia. Its mechanism of action is to block the cancer cells instead of killing it.
The resistance of the drug Imatinib usually occurs in cases of relapse patients.
The tests are to determine and somehow help medical professionals on knowing whether or not the patient is resistant to the drug.
Related posts:
- Cancer Grid Government has planned to set up a cancer grid...
- Orexican drug helps obese lose weight Obese individuals will try anything just to help them lose...
- NASA tests successfully a new system The fight for the conquest of space has become a...
- Top Mexican drug lord killed In Mexico City, a gunfight just recently happened between...
- Iran: hanged for drug trafficking Capital punishment was applied for an Iranian found guilty...
Posted by ChrisAbdey on Jul 30 2010 Filed under Health. You can follow any responses to this entry through the . You can leave a response or trackback to this entry
